4//SEC Filing
Gillies Hunter 4
Accession 0001415889-24-008771
CIK 0001798749other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 6:00 PM ET
Size
14.9 KB
Accession
0001415889-24-008771
Insider Transaction Report
Form 4
Gillies Hunter
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2024-03-18$1.74/sh+4,000$6,960→ 7,251 total - Exercise/Conversion
Common Stock
2024-03-18$2.14/sh+3,000$6,420→ 10,251 total - Sale
Common Stock
2024-03-18$25.81/sh−6,387$164,872→ 3,864 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-18−3,000→ 98,510 totalExercise: $2.14Exp: 2031-04-01→ Common Stock (3,000 underlying) - Sale
Common Stock
2024-03-18$26.40/sh−613$16,185→ 3,251 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-18−4,000→ 4,036 totalExercise: $1.74Exp: 2030-09-03→ Common Stock (4,000 underlying)
Footnotes (5)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.25 to $26.18, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.25 to $26.75, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F4]A total of 16,097 shares subject to an employee stock option were granted on September 4, 2020, with 10% of this option vested on May 1, 2020, 22.5% vested on May 1 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.
- [F5]A total of 109,640 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, with shares vesting in 48 substantially equal monthly installments.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001868997
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 6:00 PM ET
- Size
- 14.9 KB